Variant report
Variant | esv3431886 |
---|---|
Chromosome Location | chr9:118064781-118068179 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs556738396 | chr9:118064864-118064865 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs190213946 | chr9:118064874-118064875 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs576850882 | chr9:118064882-118064883 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs10982662 | chr9:118064892-118064893 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs555745693 | chr9:118064908-118064909 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs572686264 | chr9:118064929-118064930 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs138198223 | chr9:118064974-118064975 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs539231517 | chr9:118064985-118064986 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs182348889 | chr9:118064996-118064997 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs149593700 | chr9:118065080-118065081 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs543103615 | chr9:118065099-118065100 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs186042443 | chr9:118065142-118065143 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs573253570 | chr9:118065157-118065158 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs542232218 | chr9:118065165-118065166 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs188885095 | chr9:118065202-118065203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs540069594 | chr9:118065206-118065207 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs558382452 | chr9:118065208-118065209 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs181255832 | chr9:118065216-118065217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs551421190 | chr9:118065223-118065224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs34295367 | chr9:118065228-118065229 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs185364597 | chr9:118065240-118065241 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs201843975 | chr9:118065268-118065269 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs558913196 | chr9:118065273-118065274 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs530775660 | chr9:118065333-118065334 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs34666877 | chr9:118065343-118065344 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs72315519 | chr9:118065344-118065345 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs550253137 | chr9:118065351-118065352 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs191041789 | chr9:118065388-118065389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs144211085 | chr9:118065562-118065563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs562117327 | chr9:118065622-118065623 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs180719728 | chr9:118065666-118065667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs375326412 | chr9:118065707-118065708 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs565964829 | chr9:118065713-118065714 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs535308304 | chr9:118065760-118065761 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs148718911 | chr9:118065778-118065779 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs186049847 | chr9:118065803-118065804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs577811916 | chr9:118065826-118065827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs537249080 | chr9:118065912-118065913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs573924278 | chr9:118065925-118065926 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs556597524 | chr9:118065967-118065968 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs541333090 | chr9:118066006-118066007 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs573425187 | chr9:118066076-118066077 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs542386829 | chr9:118066099-118066100 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs545922734 | chr9:118066115-118066116 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs141800774 | chr9:118066189-118066190 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs79780878 | chr9:118066202-118066203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs139451243 | chr9:118066203-118066204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs565039773 | chr9:118066212-118066213 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs530685663 | chr9:118066249-118066250 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs34677964 | chr9:118066255-118066256 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Medulloblastoma | 21979893 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Myelofibrosis | 22110671 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Leukemia | 17361228 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Glioblastoma | 16823260 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Brain cancer | 20823417 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Heart disease | 21282601 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 18632612 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Gastric cancer | 17908304 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cardiac fibroma | 18329553 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 21364760 | CNVD |
Developmental delay | 21147756 | CNVD |
Lung cancer | 19147751 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Bladder cancer | 21909424 | CNVD |
Breast cancer | 21509527 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Cervical cancer | 16585170 | CNVD |
Ependymoma | 19289631 | CNVD |
Schizophrenia | 18940311 | CNVD |
Neuroticism | 17667963 | CNVD |
Cervical cancer | 17311676 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Neurodevelopmental disorder | 0 | CNVD |
Amyotrophic lateral sclerosis | 20685689 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:118060000-118073200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
2 | chr9:118064800-118065200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
3 | chr9:118067200-118067400 | Enhancers | NHEK | skin |
4 | chr9:118067200-118068400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr9:118067400-118068200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
6 | chr9:118067400-118068200 | Flanking Active TSS | NHEK | skin |
7 | chr9:118067400-118068400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
8 | chr9:118067400-118068400 | Enhancers | HMEC | breast |
9 | chr9:118067400-118068600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
10 | chr9:118068000-118068400 | Enhancers | HUES6 Cell Line | embryonic stem cell |